Preprint · CC-BY
via OpenAlex
Acarbose Impairs Gut Bacteroides Growth by Targeting Intracellular GH97 Enzymes
Haley A. Brown, Adeline L. Morris, Nicholas A. Pudlo, Ashley E. Hopkins, Eric C. Martens, Jonathan L. Golob, Nicole M. Koropatkin
bioRxiv (Cold Spring Harbor Laboratory) · 2024
Abstract
Abstract Acarbose is a type-2 diabetes medicine that inhibits dietary starch breakdown into glucose by inhibiting host amylase and glucosidase enzymes. Numerous gut species in the Bacteroides genus enzymatically break down starch and change in relative abundance within the gut microbiome in acarbose-treated individuals. To mechanistically explain this observation, we used two model starch-degrading Bacteroides , Bacteroides ovatus (Bo) and Bacteroides thetaiotaomicron (Bt). Bt growth is severely impaired by acarbose whereas Bo growth is not. The Bacteroides use a starch utilization system (Sus) to grow on starch. We hypothesized that Bo and Bt Sus enzymes are differentially inhibited by acarbose. Instead, we discovered that although acarbose primarily targets the Sus periplasmic GH97 enzymes in both organisms, the drug affects starch processing at multiple other points. Acarbose competes for transport through the Sus beta-barrel proteins and binds to the Sus transcriptional regulators. Further, Bo expresses a non-Sus GH97 (BoGH97D) when grown in starch with acarbose. The Bt homolog, BtGH97H, is not expressed in the same conditions, nor can overexpression of BoGH97D complement the Bt growth inhibition in the presence of acarbose. This work informs us about unexpected complexities of Sus function and regulation in Bacteroides , including variation between related species. Further, this indicates that the gut microbiome may be a source of variable response to acarbose treatment for diabetes. Importance Acarbose is a type 2 diabetes medication that works primarily by stopping starch breakdown into glucose in the small intestine. This is accomplished by inhibition of host enzymes, leading to better blood sugar control via reduced ability to derive glucose from dietary starches. The drug and undigested starch travel to the large intestine where acarbose interferes with the ability of some bacteria to grow on starch. However, little is known about how gut bacteria interact with acarbose, including microbes that can use starch as a carbon source. Here, we show that two gut species, Bacteroides ovatus (Bo) and Bacteroides thetaiotaomicron (Bt), respond differently to acarbose: Bt growth is inhibited by acarbose while Bo growth is not. We reveal a complex set of mechanisms involving differences in starch import and sensing behind the different Bo and Bt responses. This indicates the gut microbiome may be a source of variable response to acarbose treatment for diabetes via complex mechanisms in common gut microbes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2024.05.20.595031
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Brown, H.A., Morris, A.L., Pudlo, N.A., Hopkins, A.E., Martens, E.C., Golob, J.L., & Koropatkin, N.M. (2024). Acarbose Impairs Gut Bacteroides Growth by Targeting Intracellular GH97 Enzymes. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2024.05.20.595031
Vancouver
Brown HA, Morris AL, Pudlo NA, Hopkins AE, Martens EC, Golob JL, et al. Acarbose Impairs Gut Bacteroides Growth by Targeting Intracellular GH97 Enzymes. bioRxiv (Cold Spring Harbor Laboratory). 2024. doi:10.1101/2024.05.20.595031.
BibTeX
@unpublished{haley2024Acarbo,
title = {Acarbose Impairs Gut Bacteroides Growth by Targeting Intracellular GH97 Enzymes},
author = {Haley A. Brown and Adeline L. Morris and Nicholas A. Pudlo and Ashley E. Hopkins and Eric C. Martens and Jonathan L. Golob and Nicole M. Koropatkin},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2024},
doi = {10.1101/2024.05.20.595031},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
mBio 2024
Open access · CC-BY
Acarbose impairs gut Bacteroides growth by targeting intracellular glucosidases
ScholarWorks -A service of University of Vermont Libraries (University of Vermont) 2015
Preprint · OA
Facilitative glucose transporter and its regulation by insulin/IGF-like signaling in Caenorhabditis elegans
Aging Cell 2015
Open access · CC-BY
Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system
Clinical Cancer Research 2006
Open access · OA
Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth
Biological reviews/Biological reviews of the Cambridge Philosophical Society 2018
Open access · CC-BY
From humans to hydra: patterns of cancer across the tree of life
Cold Spring Harbor Perspectives in Biology 2015
Preprint · OA